Rocklage Scott M's Form 4 filing
Pear Therapeutics, Inc. (PEAR) · filed Sep 8, 2022
- Accession no.
- 0001209191-22-049237
- Filed
- Sep 8, 2022, 8:01 PM ET
- Trade date
- Sep 6-8, 2022
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 6 non-derivative transactions and 0 derivative transactions. Open-market sales total $1.58M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Rocklage Scott MCIK 0001219014 | 10% Owner |
| Diekman John DCIK 0001240357 | 10% Owner |
| 5AM Partners IV, LLCCIK 0001589314 | 10% Owner |
| 5AM Ventures IV, L.P.CIK 0001589315 | 10% Owner |
| 5AM Co-Investors IV, L.P.CIK 0001593361 | 10% Owner |
| Schwab Andrew J.CIK 0001598549 | 10% Owner |
| 5AM Opportunities I, L.P.CIK 0001753000 | 10% Owner |
| 5AM Opportunities I (GP), LLCCIK 0001790778 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 6, 2022 | Class A Common Stock | SSaleDisposed | −298,714 | $2.36 | −$704,965.04 | 13,965,926 | Indirect | |
| Sep 6, 2022 | Class A Common Stock | SSaleDisposed | −12,446 | $2.36 | −$29,372.56 | 581,916 | Indirect | |
| Sep 7, 2022 | Class A Common Stock | SSaleDisposed | −148,337 | $1.92 | −$284,807.04 | 13,817,589 | Indirect | |
| Sep 7, 2022 | Class A Common Stock | SSaleDisposed | −6,181 | $1.92 | −$11,867.52 | 575,735 | Indirect | |
| Sep 8, 2022 | Class A Common Stock | SSaleDisposed | −292,149 | $1.81 | −$528,789.69 | 13,525,440 | Indirect | |
| Sep 8, 2022 | Class A Common Stock | SSaleDisposed | −12,173 | $1.81 | −$22,033.13 | 563,562 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.